A biopharmaceutical company developing antiviral and antifungal therapies, including long-acting drug-Fc conjugate candidates for preventing and treating infectious diseases.
| Filed | Insider | Role | Shares | Value | |
|---|---|---|---|---|---|
| 2026-01-07 | Stein Jeffrey | director+officer | 4,262 | $339,051 | Form 4 |
from2028 — cross-site stock view. Rebuilt at publish time.